Denali Therapeutics
DNLI
DNLI
90 hedge funds and large institutions have $1.41B invested in Denali Therapeutics in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less capital invested
Capital invested by funds: $1.46B → $1.41B (-$49.1M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
90
Holding in Top 10
3
Calls
–
Puts
$2K
Top Buyers
| 1 | +$35.7M | |
| 2 | +$26.1M | |
| 3 | +$15.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$13.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$6.47M |
Top Sellers
| 1 | -$44.2M | |
| 2 | -$28.7M | |
| 3 | -$23M | |
| 4 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$5.43M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$2.7M |